239 related articles for article (PubMed ID: 31747091)
1. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies.
Di Nardo L; Pellegrini C; Di Stefani A; Del Regno L; Sollena P; Piccerillo A; Longo C; Garbe C; Fargnoli MC; Peris K
J Eur Acad Dermatol Venereol; 2020 May; 34(5):932-941. PubMed ID: 31747091
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of advanced cutaneous squamous-cell carcinoma.
Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
[TBL] [Abstract][Full Text] [Related]
5. Text mining‑based drug discovery in cutaneous squamous cell carcinoma.
Pan Y; Zhang Y; Liu J
Oncol Rep; 2018 Dec; 40(6):3830-3842. PubMed ID: 30272325
[TBL] [Abstract][Full Text] [Related]
6. Treatment approaches of advanced cutaneous squamous cell carcinoma.
Peris K; Piccerillo A; Del Regno L; Di Stefani A
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():19-22. PubMed ID: 34855254
[TBL] [Abstract][Full Text] [Related]
7. Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?
Soura E; Gagari E; Stratigos A
Curr Opin Oncol; 2019 Sep; 31(5):461-468. PubMed ID: 31394558
[TBL] [Abstract][Full Text] [Related]
8. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53.
Wang L; Xu L; Wang Y
Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682
[TBL] [Abstract][Full Text] [Related]
9. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
11. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Hernández-Guerrero T; Doger B; Moreno V
Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
13. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab].
Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF
Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.
Perry J; Ashford B; Thind AS; Gauthier ME; Minaei E; Major G; Iyer NG; Gupta R; Clark J; Ranson M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333825
[TBL] [Abstract][Full Text] [Related]
16. LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?
Egolf S; Capell BC
Expert Opin Ther Targets; 2020 Jul; 24(7):671-678. PubMed ID: 32379508
[TBL] [Abstract][Full Text] [Related]
17. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
18. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of unresectable recurrent cutaneous squamous cell carcinoma of the scalp with meningeal invasion with nivolumab monotherapy.
Fujimura T; Kambayashi Y; Tono H; Lyu C; Ohuchi K; Hashimoto A; Aiba S
Dermatol Ther; 2020 Jul; 33(4):e13672. PubMed ID: 32449226
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
